Myriad Genetics buy Piper Sandler
Start price
11.11.25
/
50%
€5.70
Target price
11.11.26
€7.36
Performance (%)
-9.65%
Price
16.01.26
€5.15
Summary
This prediction is currently active. With a performance of -9.65%, the BUY prediction for Myriad Genetics by Piper_Sandler is down slightly. This prediction currently runs until 11.11.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -8.036% | -8.036% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Piper Sandler from $9.00 to $8.50. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat